US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

iShares Biotechnology ETF

210.53

-0.5100-0.24%

Pre-market: 210.530.00000.00%07:02 EDT

Volume:1.94M

Turnover:410.08M

Market Cap:10.68B

PE:33.35

High:212.62

Open:210.89

Low:209.84

Close:211.04

52wk High:217.12

52wk Low:144.65

Shares:50.75M

Float Shares:50.75M

Volume Ratio:1.36

T/O Rate:3.82%

Dividend:0.34

Dividend Rate:0.16%

EPS(TTM):6.31

EPS(LYR):35.34

ROE:24.54%

ROA:0.10%

PB:1.31

PE(LYR):5.96

Loading ...

Overview Company News Filings

Adagene Wins NMPA IND Clearance for Novel HER2xCD3 T-Cell Engager ADG138

Filana Therapeutics announces U.S. FDA lifted clinical hold on simufilam

Vertex Pharmaceuticals announces positive results from Phase 2b inaxaplin study

Vertex Says Phase 2b Amplified Study Shows Inaxaplin Cuts Proteinuria in APOL1-Mediated Kidney Disease Patients with Modest Proteinuria

Vertex Pharmaceuticals Incorporated - Inaxaplin Reduces Uacr by -42.7% at Week 13 in Amkd with Modest Proteinuria

THOMSON REUTERS

Vertex Pharmaceuticals Incorporated - Inaxaplin Generally Safe and Well Tolerated in Both Amkd Cohorts

THOMSON REUTERS

Vertex Announces Positive Results from Phase 2B Amplified Study of Inaxaplin in Additional Populations of People with Apol1-Mediated Kidney Disease (Amkd) and Completion of Enrollment in the Phase 2/3 Amplitude Trial

THOMSON REUTERS

Analysts Offer Insights on Healthcare Companies: Amgen (AMGN), Invivyd (IVVD) and Humacyte (HUMA)

Sino Biopharmaceutical Stock Slips 1.4% in Hong Kong, Underperforms Competitors

Kolmar Biotech Finalizes Low-Risk Merger of Wholly Owned Unit MOD Materials

Nexsen Seeks ASX Trading Halt Ahead of RAPID-GBS Trial Update

iShares Biotechnology ETF Announces Dividend of R$ 0.002579964 Per Unit

Moderna Inc. Stock Climbs 12.3%, Outperforms Peers

Sector Update: Healthcare

MT Newswires Live

Exchange-Traded Funds Rise as US Equities Advance After Midday

MT Newswires Live

Sector Update: Healthcare

MT Newswires Live

InspireMD Announces Amendments to Certain Series J and Series K Warrants, Providing Potential Gross Proceeds of Up to $11 Million

Tiziana Life Sciences Completes Last Patient Visit in Phase 2a INFORM-MS Trial

Immunome initiated with a Buy at Alliance Global

Vertex Pharmaceuticals Incorporated : Leerink Partners Resumes Coverage with Outperform Rating; Target Price $594

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg1.tigeractivity.com/stock/IBB/news?page=7"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IBB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBB\",,,,,undefined,":{"symbol":"IBB","market":"US","secType":"STK","nameCN":"iShares Biotechnology ETF","latestPrice":210.53,"timestamp":1790798400000,"preClose":211.04,"halted":0,"volume":1939806,"hourTrading":{"tag":"盘前","latestPrice":210.53,"preClose":210.53,"latestTime":"07:02 EDT","volume":31,"amount":6530.7607,"timestamp":1790852576378,"change":0,"changeRate":0,"amplitude":0.002517},"delay":0,"changeRate":-0.00241660348749048,"floatShares":50750000,"shares":50750000,"eps":6.311863,"marketStatus":"Pre-Mkt","change":-0.51,"latestTime":"10-01 07:24:08 EDT","open":210.89,"high":212.62,"low":209.84,"amount":410084027.89596003,"amplitude":0.013173,"askPrice":214.45,"askSize":5,"bidPrice":210,"bidSize":25,"shortable":3,"etf":1,"ttmEps":6.311863,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1790861400000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":210.53,"sharesOutstanding":49450000,"nav":211.023541,"aum":11226452381.2,"dividendRate":0.001601,"bidAskSpread":0.000363,"preHourTrading":{"tag":"盘前","latestPrice":210.53,"preClose":210.53,"latestTime":"07:02 EDT","volume":31,"amount":6530.7607,"timestamp":1790852576378,"change":0,"changeRate":0,"amplitude":0.002517},"postHourTrading":{"tag":"盘后","latestPrice":210.53,"preClose":210.53,"latestTime":"19:40 EDT","volume":10410,"amount":2191616.46,"timestamp":1790811644228,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.3570641834940482,"impliedVol":0.2393,"impliedVolPercentile":0.58},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBB\",,,,,undefined,":{"symbol":"IBB","floatShares":50750000,"roa":"0.10%","roe":"24.54%","lyrEps":35.344796,"volumeRatio":1.3570641834940482,"shares":50750000,"dividePrice":0.3371,"high":212.62,"amplitude":0.013173,"preClose":211.04,"low":209.84,"week52Low":144.65,"pbRate":"1.31","psRate":"257.06","week52High":217.12,"institutionHeld":0,"latestPrice":210.53,"committee":0.666667,"eps":6.311863,"divideRate":0.001601,"volume":1939806,"delay":0,"ttmEps":6.311863,"open":210.89,"prevYearClose":168.77,"prevWeekClose":209.77,"prevMonthClose":210.53,"prevQuarterClose":210.53,"fiveDayClose":206.6,"twentyDayClose":210.82,"sixtyDayClose":198.23},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IBB\",params:#limit:5,,,undefined,":[{"date":"2026-09-15","symbol":"IBB","amount":0.011194,"announcedDate":"2026-09-14","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-09-15","defaultRemindTime":1789479000000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-18","payableDate":"2026-09-15","currency":"USD","dateTimestamp":1789444800000,"payDate":"2026-09-18"},{"date":"2026-06-15","symbol":"IBB","amount":0.023774,"announcedDate":"2026-06-12","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-15","defaultRemindTime":1781530200000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-18","payableDate":"2026-06-15","currency":"USD","dateTimestamp":1781496000000,"payDate":"2026-06-18"},{"date":"2026-03-17","symbol":"IBB","amount":0.121818,"announcedDate":"2026-03-16","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-17","defaultRemindTime":1773754200000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-20","payableDate":"2026-03-17","currency":"USD","dateTimestamp":1773720000000,"payDate":"2026-03-20"},{"date":"2025-12-16","symbol":"IBB","amount":0.183099,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-19","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-19"},{"date":"2025-09-16","symbol":"IBB","amount":0.082843,"announcedDate":"2025-09-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-16","defaultRemindTime":1758029400000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-19","payableDate":"2025-09-16","currency":"USD","dateTimestamp":1757995200000,"payDate":"2025-09-19"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IBB\",market:\"US\",,,undefined,":[{"executeDate":"2016-12-22","recordDate":"2016-12-27","paymentDate":"2016-12-29","value":0.091903,"currency":"USD"},{"executeDate":"2017-03-24","recordDate":"2017-03-28","paymentDate":"2017-03-30","value":0.29898,"currency":"USD"},{"executeDate":"2017-06-27","recordDate":"2017-06-29","paymentDate":"2017-06-30","value":0.176803,"currency":"USD"},{"executeDate":"2017-09-26","recordDate":"2017-09-27","paymentDate":"2017-09-29","value":0.118654,"currency":"USD"},{"executeDate":"2018-06-26","recordDate":"2018-06-27","paymentDate":"2018-07-02","value":0.15606,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IBB\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IBB\",pageSize:20,pageCount:7,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2669144262","title":"Adagene Wins NMPA IND Clearance for Novel HER2xCD3 T-Cell Engager ADG138","url":"https://stock-news.laohu8.com/highlight/detail?id=2669144262","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669144262?lang=en_us&edition=fundamental","pubTime":"2026-09-22 20:27","pubTimestamp":1790080070,"startTime":"0","endTime":"0","summary":"Adagene ( ($ADAG) ) has issued an announcement. Adagene Inc., a platform-driven, clinical-stage biotechnology company listed on Nasdaq, specializes...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/adagene-wins-nmpa-ind-clearance-for-novel-her2xcd3-t-cell-engager-adg138?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/adagene-wins-nmpa-ind-clearance-for-novel-her2xcd3-t-cell-engager-adg138?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XT","RSPH","DARP","IEIH","BK4585","BK4588","LCLG","IBB","LNGR","BBC","ADAG","NQmain","SYNB","JDOC","BBP","FHLC","BK4139","FWD","AGNG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669442921","title":"Filana Therapeutics announces U.S. FDA lifted clinical hold on simufilam","url":"https://stock-news.laohu8.com/highlight/detail?id=2669442921","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669442921?lang=en_us&edition=fundamental","pubTime":"2026-09-22 20:20","pubTimestamp":1790079649,"startTime":"0","endTime":"0","summary":"Filana Therapeutics (FLNA) announced that the U.S. Food and Drug Administration, FDA, has lifted the clinical hold on the Company’s investigational...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/filana-therapeutics-announces-u-s-fda-lifted-clinical-hold-on-simufilam-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/filana-therapeutics-announces-u-s-fda-lifted-clinical-hold-on-simufilam-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4007","FLNA","SYNB","BK4585","IBB","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669144313","title":"Vertex Pharmaceuticals announces positive results from Phase 2b inaxaplin study","url":"https://stock-news.laohu8.com/highlight/detail?id=2669144313","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669144313?lang=en_us&edition=fundamental","pubTime":"2026-09-22 20:15","pubTimestamp":1790079331,"startTime":"0","endTime":"0","summary":"The company states: “Vertex Pharmaceuticals (VRTX) announced positive results from the Phase 2b AMPLIFIED study of inaxaplin in people with APOL1-m...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/vertex-pharmaceuticals-announces-positive-results-from-phase-2b-inaxaplin-study-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/vertex-pharmaceuticals-announces-positive-results-from-phase-2b-inaxaplin-study-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0320765992.SGD","IE00B4R5TH58.HKD","LU0234570918.USD","BK4532","LU1093756325.SGD","LU0109394709.USD","LU1778281490.HKD","LU0256863811.USD","GNMX","LU1585245621.USD","LU2362540622.SGD","IE00B19Z9P08.USD","IE00B2B36J28.USD","PBE","LU2236285917.USD","LU1674673428.USD","LU2089984988.USD","IE00BFTCPJ56.SGD","BK4023","VERX","IE00B19Z3581.USD","BK4139","BK4588","IE0002141913.USD","BBH","IBB","BIB","IBBQ","LU1815336091.USD","LU0757428866.USD","LU1035775433.USD","LU0289739699.SGD","IDNA","SG9999001176.SGD","LU0823416689.USD","BK4567","VRTX","TBXU","IE00BJT1NW94.SGD","LU0432979614.USD","LU1093756168.USD","LU1674673691.USD","LU0061475181.USD","IE00B19Z9Z06.USD","IE0009355771.USD","LU1430594728.SGD","LU2462157665.USD","SG9999013999.USD","IE00B19Z3B42.SGD","LU2237438978.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669177141","title":"Vertex Says Phase 2b Amplified Study Shows Inaxaplin Cuts Proteinuria in APOL1-Mediated Kidney Disease Patients with Modest Proteinuria","url":"https://stock-news.laohu8.com/highlight/detail?id=2669177141","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669177141?lang=en_us&edition=fundamental","pubTime":"2026-09-22 20:02","pubTimestamp":1790078577,"startTime":"0","endTime":"0","summary":"Vertex says Phase 2b AMPLIFIED study shows inaxaplin cuts proteinuria in APOL1-mediated kidney disease patients with modest proteinuriaVertex reported positive Phase 2b AMPLIFIED results for inaxaplin","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nNDL8CHhBr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIB","IE0002141913.USD","IBB","LU0823416689.USD","BBH","LU1674673691.USD","BK4532","SGXZ57979304.SGD","LU2362541273.HKD","PBE","IE00BJT1NW94.SGD","LU0109394709.USD","GNMX","LU2089984988.USD","LU2462157665.USD","VRTX","SG9999001176.SGD","IE00B2B36J28.USD","LU2468319806.SGD","LU2362541513.USD","TBXU","LU0061475181.USD","BK4588","BK4567","LU0058720904.USD","LU1093756325.SGD","LU2324357040.USD","IE0002270589.USD","IE00B19Z3B42.SGD","IE00B19Z9Z06.USD","IE00BZ9MQY76.HKD","IBBQ","IE0009355771.USD","LU0432979614.USD","LU0889565916.HKD","IE00B19Z9P08.USD","LU0320765992.SGD","LU1093756168.USD","LU1069344957.HKD","LU1674673428.USD","SG9999013999.USD","LU0079474960.USD","BK4585","LU0256863811.USD","LU1035775433.USD","LU2237438978.USD","IDNA","BK4139","IE00B19Z3581.USD","IE00BFTCPJ56.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669419861","title":"Vertex Pharmaceuticals Incorporated - Inaxaplin Reduces Uacr by -42.7% at Week 13 in Amkd with Modest Proteinuria","url":"https://stock-news.laohu8.com/highlight/detail?id=2669419861","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669419861?lang=en_us&edition=fundamental","pubTime":"2026-09-22 20:00","pubTimestamp":1790078403,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nTUA6RPXRQ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1093756325.SGD","IE00B19Z9P08.USD","LU2324357040.USD","IE00BJT1NW94.SGD","LU1430594728.SGD","LU1674673428.USD","LU1778281490.HKD","IE00B19Z3581.USD","LU2236285917.USD","LU2237438978.USD","BIB","LU2362541513.USD","LU1069344957.HKD","IE00B19Z9Z06.USD","BK4585","LU0079474960.USD","LU1093756168.USD","LU1585245621.USD","LU2362541273.HKD","LU0889565916.HKD","BBH","LU0234570918.USD","GNMX","LU0109394709.USD","LU2417539215.USD","LU0417517546.SGD","SGXZ57979304.SGD","SG9999001176.SGD","IE0002141913.USD","IBBQ","VRTX","LU2468319806.SGD","IBB","TBXU","LU2362540622.SGD","IDNA","BK4139","IE00B894F039.SGD","LU2456880835.USD","LU0289739699.SGD","LU0823416689.USD","IE0009355771.USD","IE00B4R5TH58.HKD","LU2462157665.USD","IE0002270589.USD","PBE","LU0256863811.USD","IE00BJJMRZ35.SGD","LU1674673691.USD","IE00B2B36J28.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669419041","title":"Vertex Pharmaceuticals Incorporated - Inaxaplin Generally Safe and Well Tolerated in Both Amkd Cohorts","url":"https://stock-news.laohu8.com/highlight/detail?id=2669419041","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669419041?lang=en_us&edition=fundamental","pubTime":"2026-09-22 20:00","pubTimestamp":1790078403,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nTUA6RPXRQ:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0079474960.USD","IBB","BK4533","PBE","LU0234570918.USD","LU1585245621.USD","LU2237438978.USD","VRTX","BK4532","BK4567","LU1674673428.USD","LU2362541513.USD","GNMX","LU2089984988.USD","LU0432979614.USD","LU1035775433.USD","IE0002270589.USD","LU2456880835.USD","LU0109394709.USD","LU1778281490.HKD","IE00BJJMRZ35.SGD","LU0256863811.USD","BK4585","IE0002141913.USD","BK4139","IE00B4R5TH58.HKD","LU0320765992.SGD","LU2324357040.USD","IDNA","LU0058720904.USD","SGXZ57979304.SGD","LU2362541273.HKD","LU0889565916.HKD","LU1069344957.HKD","BIB","IE00BJT1NW94.SGD","SG9999001176.USD","BBH","BK4588","IE00B19Z9P08.USD","SG9999001176.SGD","LU2462157665.USD","LU0061475181.USD","TBXU","SG9999013999.USD","LU1093756325.SGD","IBBQ","LU2417539215.USD","IE00B19Z9Z06.USD","IE00BZ9MQY76.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669141954","title":"Vertex Announces Positive Results from Phase 2B Amplified Study of Inaxaplin in Additional Populations of People with Apol1-Mediated Kidney Disease (Amkd) and Completion of Enrollment in the Phase 2/3 Amplitude Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2669141954","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669141954?lang=en_us&edition=fundamental","pubTime":"2026-09-22 20:00","pubTimestamp":1790078403,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nTUA6RPXRQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0889565916.HKD","LU2237438978.USD","LU0823416689.USD","IE00B19Z9P08.USD","LU1035775433.USD","LU0109394709.USD","LU1069344957.HKD","LU1093756325.SGD","BK4532","SG9999013999.USD","BIB","IDNA","IE00BZ9MQY76.HKD","LU2236285917.USD","IE00B4R5TH58.HKD","LU0256863811.USD","IE00B19Z3581.USD","BK4585","LU1778281490.HKD","LU1674673691.USD","LU0079474960.USD","IBB","IE0002141913.USD","IE00B2B36J28.USD","PBE","LU1585245621.USD","BK4533","LU0289739699.SGD","IE00BJT1NW94.SGD","LU1674673428.USD","LU2456880835.USD","SG9999001176.USD","IE00B19Z3B42.SGD","IE0002270589.USD","BK4567","SGXZ57979304.SGD","VRTX","IBBQ","LU0058720904.USD","LU0320765992.SGD","LU0432979614.USD","GNMX","TBXU","BK4139","LU0234570918.USD","LU2089984988.USD","BBH","LU0061475181.USD","LU0417517546.SGD","SG9999001176.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669143096","title":"Analysts Offer Insights on Healthcare Companies: Amgen (AMGN), Invivyd (IVVD) and Humacyte (HUMA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2669143096","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669143096?lang=en_us&edition=fundamental","pubTime":"2026-09-22 18:10","pubTimestamp":1790071809,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Amgen (AMGN), Invivyd (IVVD) and Humacyte (HUMA). ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-amgen-amgn-invivyd-ivvd-and-humacyte-huma-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-amgen-amgn-invivyd-ivvd-and-humacyte-huma-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PJP","IBB","IE0009355771.USD","LU2242646821.SGD","LU0889565916.HKD","HUMA","BK4563","IE00B2B36J28.USD","LU0109394709.USD","LU2468319806.SGD","LU2089984988.USD","AMGN","LU1057294990.SGD","XBI","LU1571399168.USD","BBH","BK4139","BK4539","LU0128526141.USD","LU1983299246.USD","LU0868494617.USD","TBXU","BK4137","IE0002141913.USD","LU2242652126.USD","LABU","BK4534","SG9999001440.SGD","BK4599","XLV","IE00BJJMRZ35.SGD","IE00BFTCPJ56.SGD","PBE","IE00BJT1NW94.SGD","BK4566","BK4533","IVVD","LU1023059063.AUD","LU0058720904.USD","LU0122379950.USD","IBBQ","LU0029874061.USD","BIB","LU1061106388.HKD","BK4588","IE00B4R5TH58.HKD","HCSG","LU0289739699.SGD","LU0320765992.SGD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669511784","title":"Sino Biopharmaceutical Stock Slips 1.4% in Hong Kong, Underperforms Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2669511784","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669511784?lang=en_us&edition=fundamental","pubTime":"2026-09-22 16:32","pubTimestamp":1790065920,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sino Biopharmaceutical Ltd. slipped 1.4% to 5.84 Hong Kong dollars on what proved to be an all-around positive trading session for the Hong Kong stock market, with the Hang Seng Index rising 0.2% to 25087.75.Sino Biopharmaceutical Ltd. closed 32% short of its 52-week high of HK$8.56, which the company reached Sept. 23.The stock underperformed when compared to some of its competitors, as CSPC Pharmaceutical Group Ltd. rose 1.1% and Amgen Inc. remained unchanged.Trading volume totaled 87.2 million shares, compared to the 50-day average of 88.8 million shares.Data source: Dow Jones Market Data, FactSet","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999001440.SGD","BK4533","IE00B4R5TH58.HKD","IBB","LU1061106388.HKD","IE00BZ08YR35.GBP","LU0109394709.USD","LU0868494617.USD","BK4566","LU1571399168.USD","BK4599","LU0320765992.SGD","IE00BZ08YS42.EUR","BK4581","BK1589","01177","TBXU","BK1191","LU0889565916.HKD","IE00BJJMRZ35.SGD","BK1521","LU2112291526.USD","IE0002141913.USD","PBE","HK0000165453.HKD","BK4534","IE00BJT1NW94.SGD","LU2468319806.SGD","BK4585","IE0009355771.USD","IE00BZ08YT58.USD","BK4139","LU1983299246.USD","LU1057294990.SGD","AMGN","PJP","LU0122379950.USD","BIB","IE00BFTCPJ56.SGD","BK1515","LU0058720904.USD","LU1023059063.AUD","BBH","BK4588","IE00B2B36J28.USD","LU2242646821.SGD","LU0289739699.SGD","LU2089984988.USD","IBBQ","LU2242652126.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669192951","title":"Kolmar Biotech Finalizes Low-Risk Merger of Wholly Owned Unit MOD Materials","url":"https://stock-news.laohu8.com/highlight/detail?id=2669192951","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669192951?lang=en_us&edition=fundamental","pubTime":"2026-09-22 09:14","pubTimestamp":1790039644,"startTime":"0","endTime":"0","summary":"WOOJUNG BIO, Inc. ( ($KR:215380) ) has issued an update. Kolmar Biotech Co., Ltd., a biotechnology and advanced materials company based in Hwaseong...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/kolmar-biotech-finalizes-low-risk-merger-of-wholly-owned-unit-mod-materials?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/kolmar-biotech-finalizes-low-risk-merger-of-wholly-owned-unit-mod-materials?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBI","ARKG","IBB","AGNG","TINT","FHLC","DARP","FWD","RSPH","XT","BK4581","JDOC","BK4585","UYM","LNGR","TYNE","BBP","BK4544","BK4588","SYNB","IEIH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669199837","title":"Nexsen Seeks ASX Trading Halt Ahead of RAPID-GBS Trial Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2669199837","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669199837?lang=en_us&edition=fundamental","pubTime":"2026-09-22 07:34","pubTimestamp":1790033657,"startTime":"0","endTime":"0","summary":"Nexsen Limited ( ($AU:NXN) ) just unveiled an announcement. Nexsen Limited, trading on the ASX as NXN, operates in the healthcare and biotechnology...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/nexsen-seeks-asx-trading-halt-ahead-of-rapid-gbs-trial-update?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/nexsen-seeks-asx-trading-halt-ahead-of-rapid-gbs-trial-update?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AGNG","TCAF","CGCV","BK4585","JDOC","FHLC","XT","IBB","SYNB","NOBL","BBP","BK4550","FWD","VHT","LNGR","BK4588","DARP","IEIH","IXJ","RSPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669819362","title":"iShares Biotechnology ETF Announces Dividend of R$ 0.002579964 Per Unit","url":"https://stock-news.laohu8.com/highlight/detail?id=2669819362","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669819362?lang=en_us&edition=fundamental","pubTime":"2026-09-22 04:51","pubTimestamp":1790023874,"startTime":"0","endTime":"0","summary":"iShares Biotechnology ETF announces dividend of R$ 0.002579964 per unitiShares Biotechnology ETF announced a 3Q 2026 dividend of R$ 0.002579964 per unit.Units trade ex-dividend on Sept. 15, 2026.Payme","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nNDL718W0J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","IBB","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669619383","title":"Moderna Inc. Stock Climbs 12.3%, Outperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2669619383","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669619383?lang=en_us&edition=fundamental","pubTime":"2026-09-22 04:33","pubTimestamp":1790022780,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Moderna Inc. jumped 12.3% to $172.94 on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index rising 2.3% to 27,122.09 and the Dow Jones Industrial Average rising 0.7% to 52,048.83.Moderna Inc. closed 2.1% short of its 52-week high of $176.66, which the company reached on August 19th.The stock outperformed some of its peers, as Johnson & Johnson fell 0.2% to $269.47, Pfizer Inc. rose 0.3% to $27.74, and Gilead Sciences Inc. rose 0.30% to $150.56.Trading volume totaled 20.9 million, compared to the 50-day average of 17.9 million.Data source: Dow Jones Market Data, FactSet","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIB","IBB","LU1778281490.HKD","BBH","BK4532","BK4501","BK4578","IE00BSNM7G36.USD","LU0859254822.USD","LU0109394709.USD","LU2089984988.USD","BMED","IE00B7SZLL34.SGD","LU1066051498.USD","GNOM","LU0965509101.SGD","GILD","LU0122379950.USD","LU1066053197.SGD","LU1430594728.SGD","LU2468319806.SGD","TBXU","LU0058720904.USD","MRNY","TMED","LU0861579265.USD","IE0002270589.USD","LU0289739699.SGD","LU1023059063.AUD","LU0234570918.USD","IBBQ","LU0889565916.HKD","LU0320765992.SGD","SG9999015952.SGD","MEDI","WDNA","LU1674673428.USD","LU1934455194.USD","LGHT","BK4534","IDNA","MRNA","SG9999015986.USD","LU1061106388.HKD","BK4139","BK4548","LU1839511570.USD","BK4533","LU0882574055.USD","MRNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669081160","title":"Sector Update: Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2669081160","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669081160?lang=en_us&edition=fundamental","pubTime":"2026-09-22 03:21","pubTimestamp":1790018463,"startTime":"0","endTime":"0","summary":"Healthcare stocks rose late Monday afternoon with the NYSE Healthcare Index increasing 0.6% and the State Street Health Care Select Sector SPDR ETF  adding 0.8%.The iShares Biotechnology ETF  climbed 1.4%.In corporate news, Eli Lilly's  oral drug Foundayo now makes up one-third of new GLP-1 pill patients, CNBC reported, citing CEO Dave Ricks. Lilly broke ground on a $6.5 billion Houston manufacturing plant expected to be operational by 2030, the report also said. Lilly shares rose 0.9%.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE0009355771.USD","IE00B2B36J28.USD","LU0823434583.USD","LU0316494557.USD","LU0256863902.USD","LU0109394709.USD","IE00BFSS8Q28.SGD","IE00BN29S564.USD","LU0225283273.USD","LU2089283258.USD","LU2211815571.USD","LU0640476718.USD","LU1814569148.SGD","LU2168563687.JPY","LU2271345857.HKD","LU0109391861.USD","LU2023251221.USD","SG9999014898.SGD","LU2471134952.CNY","CURE","LU2750360641.GBP","FTXH","LU0353189680.USD","LU0823434740.USD","LU0122379950.USD","ELIS","LU0820561818.USD","SG9999018865.SGD","LU0094547139.USD","SG9999013999.USD","LU2168564495.EUR","IE00B775H168.HKD","IE00BFSS7M15.SGD","VHT","LU0079474960.USD","IYH","LU2746668461.USD","LU2756315318.SGD","LU1868836591.USD","IBB","LU2087625088.SGD","LU2168564065.EUR","BK4585","LU0006306889.USD","LU0353189763.USD","LU0354030511.USD","LU1979441026.SGD","LU2462157665.USD","LU1917777945.USD","LABU","LU1035775433.USD","LU2063271972.USD","IE00BJT1NW94.SGD","LU1366192091.USD","IE00B4R5TH58.HKD","ILDR","LU0256863811.USD","BK4581","SG9999018857.SGD","SGXZ31699556.SGD","LLYX","LU1548497426.USD","LU2552382132.HKD","WDNA","LU1323610961.USD","LU2896262040.SGD","FHLC","LU1145028129.USD","LU0203202063.USD","IE00BJLML261.HKD","LU0097036916.USD","SG9999001176.USD","LU0471298777.SGD","LU1720051017.SGD","LU2602419157.SGD","LU2552382058.USD","IE00BKDWB100.SGD","LU1974910355.USD","LU1291159041.SGD","LU2023250330.USD","LU0266013472.USD","LU2023250504.SGD","LLII","LU2111349929.HKD","LU2746668974.SGD","LU0823416689.USD","IXJ","LU0889565916.HKD","LU0964807845.USD","PPH","LU0417517546.SGD","IE00B4JS1V06.HKD","LU0203201768.USD","LLYZ","MEDX","LU0345770308.USD","LU0689472784.USD","LU2456880835.USD","PJP","LU2491050154.USD","LU1868837136.USD","LU1983299246.USD","LU1093756325.SGD","BK4533","LU1551013342.USD","RXL","LU0289739699.SGD","LU0787776722.HKD","THNR","IE00BKPKM429.USD","IE0004445239.USD","LU1064131342.USD","IE00BJJMRY28.SGD","LU0106261372.USD","LU0323591593.USD","LU1232071149.USD","LU2237443978.SGD","XBI","HRTS","LU0320765992.SGD","IE00BK4W5L77.USD","LU2756315664.SGD","SG9999001176.SGD","LU2028103732.USD","LU1061106388.HKD","LU1551013425.SGD","ELIL","IE00BFTCPJ56.SGD","LU1069344957.HKD","LU0943347566.SGD","LU1868836914.USD","IE00BK4W5M84.HKD","LU1804176565.USD","MHIP","LU2264538146.SGD","LU2361044865.SGD","LU0456855351.SGD","LU0471298694.HKD","LU2361045086.USD","LU0096364046.USD","LU1720051108.HKD","LU0385154629.USD","LU0882574139.USD","IE0005OL40V9.USD","LU2361044949.HKD","LU2237438978.USD","SG9999014906.USD","JDOC","BK4599","SGXZ99366536.SGD","LU2461242641.AUD","BK4534","LU2324357040.USD","LU2112291526.USD","BK4588","BK4007","LU2750360997.AUD","LU1127390331.HKD","LU2106854487.HKD","LU2236285917.USD","IE00BJJMRX11.SGD","LU0320765059.SGD","IE0004445015.USD","LU1629891620.HKD","CANC","LU0158827948.USD","LU0238689110.USD","LU0345770993.USD","LU1868836757.USD","LU1691799644.USD","SGXZ81514606.USD","LU2468319806.SGD","IE00B7KXQ091.USD","LU0672654240.SGD","BK4516","LU0882574055.USD","TRUH","LU0466842654.USD","LU0786609619.USD","IE00B1BXHZ80.USD","LU1280957306.USD","LU2089984988.USD","LU2237443622.USD","LU0820562030.AUD","LU1712237335.SGD","LU1093756168.USD","LU0114720955.EUR","LU0058720904.USD","LU2213496289.HKD","LU1988902786.USD","LU2491049909.HKD","AGNG","SG9999015986.USD","TMED","LU2168564222.USD","SGXZ51526630.SGD","LU0158827781.USD","LU0234572021.USD","LU0061475181.USD","LU0174119429.USD","LU0354030438.USD","LU2237443465.HKD","LU1057294990.SGD","LU2237443549.SGD","SG9999015978.USD","LU1989771016.USD","LU2471134523.USD","LU0820561909.HKD","LU1267930730.SGD","LU0133085943.USD","SG9999014880.SGD","IE0002141913.USD","LU2108987350.USD","IE00BJJMRZ35.SGD","LU2168564149.EUR","LU2417539215.USD","LU0198837287.USD","LU2471134796.USD","SG9999015945.SGD","LU0210536198.USD","LU2491050071.SGD","IE00B1XK9C88.USD","LU2237443382.USD","LLY","GDOC","IE00BWXC8680.SGD","LU2462591350.SGD","SGXZ57979304.SGD","XLV","LU2089284900.SGD","LU2360106947.USD","SG9999014914.USD","GB00BDT5M118.USD","LU2237443895.HKD","MEDI","LU2357305700.SGD","LU2471134879.HKD","SG9999017495.SGD","LU2265009873.SGD","LU0683600562.USD","LU0708995401.HKD","LU0432979614.USD","LU1623119135.USD","OZEM","SG9999015952.SGD","LU1868837300.USD","LU1023059063.AUD","IHE","LU2552382215.SGD","IE0001KFT4U8.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669538167","title":"Exchange-Traded Funds Rise as US Equities Advance After Midday","url":"https://stock-news.laohu8.com/highlight/detail?id=2669538167","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669538167?lang=en_us&edition=fundamental","pubTime":"2026-09-22 01:07","pubTimestamp":1790010473,"startTime":"0","endTime":"0","summary":"Broad Market IndicatorsBroad-market exchange-traded funds IWM and IVV were higher. Actively traded Invesco QQQ Trust (QQQ) added 2.5%.US equity indexes rose as mega-cap technology names perked up amid","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CBXY","BK4534","GBTC","ETH","BK4550","QQQ","TQQQ","FGDL","CBTJ","IYJ","BK4581","FAZ","GLL","USG","ETCO","QQQM","XAGUSD.FOREX","BTCC","BFAP","BETE","QLD","IYW","MNRS","FBTC","NJUL","BPI","IAUM","XRT","BK4547","BK4570","BAR","SQQQ","DEFI","CBXO","IBIT","SETH","YBTC","BRRR","BK4588","LABU","CBOJ","BCCC","XBI","XLV","CBTY","XLI","ETQ","ARKB","IGLD","ETHD","IAUI","EZBC","BTCW","BTCZ","XLK","BTF","ETHT","QBF","RETL","BITU","XLPU","BTC.USD.CC","CBXJ","CBTO","VDC","BITY","AAAU","ZSL","PSQ","IYE","BGLD","BITI","SOXL","XLE","BTCI","SOXS","XLP","SBIT","UCO","BETH","BTCO","SLV","GLDM","GLDY","GPIQ","TECL","UNG","UGL","BITO","BAGY","VIS","XLF","HODL","XLY","FAS","XSD","BITB","BITX","QMAR","RTH","BFJL","SHNY","BTCL","IBB","TETH","XAUUSD.FOREX","NDX","DGZ","QQQX","QID","XLPD","SCO","DULL","BTC","KGLD","CBOO","SGOL","DGP","GLD","BK4504","BK4561","AGQ","VHT","YGLD","QDEC","BK4585","IAU","IYH","DFII","NOCT","OUNZ","EETH","GCPU","USO","ESK","SOXX","TQQY","DZZ","NAPR","BTRN","SIVR","CBOA","ETH.USD.CC","NJAN","CBXA","CBTA","IGM","BK4593","MAXI","XBTY","CBOY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669668841","title":"Sector Update: Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2669668841","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669668841?lang=en_us&edition=fundamental","pubTime":"2026-09-21 21:01","pubTimestamp":1789995684,"startTime":"0","endTime":"0","summary":"Healthcare stocks were steady premarket Monday, with the iShares Biotechnology ETF  inactive and the State Street Health Care Select Sector SPDR ETF  down a slight 0.1%.Novo Nordisk  is facing shareholder calls to develop new medicines and pursue acquisitions so that it could lower its dependence on its popular weight-loss treatments, the Financial Times reported, citing the company's investors. Shares of Novo Nordisk were down 4.7% pre-bell.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NVOX","BK4585","IE00BKVL7J92.USD","BK4588","LABU","LU1093756168.USD","NVOH","BK4007","BK4581","NVO","NVOC","BK4532","IBB","XLV","OZEM","XBI","THNR","LU1093756325.SGD","LU0154236417.USD","PPH","BK4599","IE00BZ1G4Q59.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669316610","title":"InspireMD Announces Amendments to Certain Series J and Series K Warrants, Providing Potential Gross Proceeds of Up to $11 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2669316610","media":"GlobeNewswire","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669316610?lang=en_us&edition=fundamental","pubTime":"2026-09-21 21:00","pubTimestamp":1789995600,"startTime":"0","endTime":"0","summary":"- Amendments align trigger event of existing warrants with anticipated FDA approval of CGuard Prime 80 cm, which the Company continues to anticipate in Q4 2026 - - The amended warrants, if exercised i","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/21/3365503/0/en/inspiremd-announces-amendments-to-certain-series-j-and-series-k-warrants-providing-potential-gross-proceeds-of-up-to-11-million.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NSPR","BK4198","IBB","IDNA","RSPH","MRNY","BK4585","NVIB","BMED","BBP","TBXU","MRNX","BK4588","PINK","LFSC","PSCH","SYNB","MEDI","GNMX","IEIH","GDOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669684681","title":"Tiziana Life Sciences Completes Last Patient Visit in Phase 2a INFORM-MS Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2669684681","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669684681?lang=en_us&edition=fundamental","pubTime":"2026-09-21 19:27","pubTimestamp":1789990051,"startTime":"0","endTime":"0","summary":"Tiziana Life Sciences ( ($TLSA) ) has shared an announcement. Tiziana Life Sciences Ltd, a clinical-stage biotechnology company specializing in imm...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/tiziana-life-sciences-completes-last-patient-visit-in-phase-2a-inform-ms-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/tiziana-life-sciences-completes-last-patient-visit-in-phase-2a-inform-ms-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IBB","DARP","BK4588","IEIH","BBC","BBP","LNGR","BK4585","XT","SYNB","RSPH","JDOC","FWD","AGNG","FHLC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669893168","title":"Immunome initiated with a Buy at Alliance Global","url":"https://stock-news.laohu8.com/highlight/detail?id=2669893168","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669893168?lang=en_us&edition=fundamental","pubTime":"2026-09-21 19:05","pubTimestamp":1789988705,"startTime":"0","endTime":"0","summary":"Alliance Global initiated coverage of Immunome (IMNM) with a Buy rating and $32 price target Immunome is a biotechnology company focused on develop...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/immunome-initiated-with-a-buy-at-alliance-global-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/immunome-initiated-with-a-buy-at-alliance-global-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["JDOC","DARP","FWD","XT","BK4585","BK4563","IEIH","BK4139","IMNM","BBP","LNGR","AGNG","SYNB","FHLC","IBB","BK4588","RSPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669315293","title":"Vertex Pharmaceuticals Incorporated : Leerink Partners Resumes Coverage with Outperform Rating; Target Price $594","url":"https://stock-news.laohu8.com/highlight/detail?id=2669315293","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669315293?lang=en_us&edition=fundamental","pubTime":"2026-09-21 18:03","pubTimestamp":1789985027,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nFWN45A0U1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2468319806.SGD","LU1069344957.HKD","GNMX","VRTX","SG9999013999.USD","IE00B894F039.SGD","LU1778281490.HKD","IE00B19Z9P08.USD","LU2456880835.USD","IBBQ","IE0009355771.USD","LU1585245621.USD","LU0061475181.USD","PBE","IE00BJT1NW94.SGD","LU2462157665.USD","IBB","LU0823416689.USD","IE00BJJMRZ35.SGD","LU2236285917.USD","SG9999001176.SGD","BK4533","LU0109394709.USD","BK4139","BK4532","LU0234570918.USD","LU2089984988.USD","BK4567","LU0320765992.SGD","LU0058720904.USD","LU2417539215.USD","IDNA","LU1674673428.USD","IE00B19Z3581.USD","LU2362541513.USD","LU2324357040.USD","LU1093756325.SGD","LU2362541273.HKD","IE00BFTCPJ56.SGD","LU1035775433.USD","IE00B4R5TH58.HKD","IE00BZ9MQY76.HKD","LU2362540622.SGD","BK4588","LU0256863811.USD","LU0289739699.SGD","BIB","TBXU","BBH","LU1093756168.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":7,"totalSize":200,"code":"91000000","status":"200"}]}}